Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL2110670

VABICASERIN
🧪 Phase II
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
🧪 Phase II
c1cc2c3c(c1)[C@H]1CCC[C@H]1CN3CCNC2

Basic Information

ChEMBL ID CHEMBL2110670
Name VABICASERIN
Phase Phase II
Structure Type MOL
InChI Key NPTIPEQJIDTVKR-STQMWFEESA-N

Known Names

Vabicaserin Vabicaserina Vabicaserine
1
Targets
3
Activities
2
Assay Types
0
PK Parameters
4
Publications
3
Known Names
1
Indications

Molecular Properties

228.3
MW (Da)
2.49
ALogP
2
HBA
1
HBD
15.3
PSA (Ų)
0.73
QED
0
Ro5 Violations
0
Rot. Bonds

Drug Information

Molecule Type Small molecule
Chirality Single Enantiomer

Flags

Natural Product
USAN Stem -caserin
USAN Year 2005

Extended Properties

Molecular Formula C15H20N2
MW 228.34
Aromatic Rings 1
Heavy Atoms 17
NP-Likeness 0.08

Indications

Schizophrenia

Activity Summary

EC50 2 meas. best 8.1
Ki 1 meas. best 8.52

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
5-hydroxytryptamine receptor 2C
CHEMBL225
Ki 8.52 8.52 3.0 1
5-hydroxytryptamine receptor 2C
CHEMBL225
EC50 8.1 8.1 8.0 2

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
24491146 10.1021/jm401802f 5-hydroxytryptamine receptor 2C 2
25633969 10.1021/jm5019274 5-hydroxytryptamine receptor 2C 2
35939391 10.1021/acs.jmedchem.2c00633 5-hydroxytryptamine receptor 2C 2
25633969 10.1021/jm5019274 5-hydroxytryptamine receptor 2B 1

Data from ChEMBL 36 via Core Engine